Synergistic Signaling of Tumor Cell Invasiveness by Hepatocyte Growth Factor and Hypoxia |
| |
Authors: | Young H Lee Bethanie L Morrison Donald P Bottaro |
| |
Institution: | From the ‡Urologic Oncology Branch and ;the §Lymphoid Malignancies Branch, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892 |
| |
Abstract: | Hepatocyte growth factor (HGF) signaling promotes tumor invasiveness in renal cell carcinoma (RCC) and other cancers. In clear cell RCC, VHL loss generates pseudohypoxia that exacerbates HGF-driven invasion through β-catenin deregulation. Hypoxia also enhances HGF-driven invasiveness by papillary RCC cells, but in the absence of VHL, loss signaling integration involves three parallel routes: 1) hypoxia-induced reactive oxygen species production and decreased DUSP2 expression, leading to enhanced mitogen-activated protein kinase (MAPK) cascade activation; 2) reactive oxygen species-induced diacylglycerol production by phospholipase Cγ, leading to protein kinase C activation and increased protein phosphatase-2A activity, thereby suppressing HGF-induced Akt activation; and 3) a profound shift from HGF-enhanced, proliferation-oriented metabolism to autophagy-dependent invasion and suppression of proliferation. This tripartite signaling integration was not unique to RCC or HGF; in RCC cells, invasive synergy induced by the combination of hypoxia and epidermal growth factor occurred through the same mechanism, and in estrogen receptor-positive breast cancer cells, this mechanism was suppressed in the absence of estrogen. These results define the molecular basis of growth factor and hypoxia invasive synergy in VHL-competent papillary RCC cells, illustrate the plasticity of invasive and proliferative tumor cell states, and provide signaling profiles by which they may be predicted. |
| |
Keywords: | Cancer Cell Invasion Hepatocyte Growth Factor/Scatter Factor (HGF/SF) Hypoxia Tumor Metastasis |
|
|